Atorvastatin and rosuvastatin improve physiological parameters and alleviate immune dysfunction in metabolic disorders
Authors:
- 1 September 2016
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 478 (3) , 1242-1247
Abstract
No abstract availableKeywords
Funding Information
- Sahmyook University
This publication has 31 references indexed in Scilit:
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsJACC, 2014
- RETRACTED ARTICLE: Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed ratsArchives of Pharmacal Research, 2012
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsThe Lancet, 2010
- Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-AnalysisDiabetes Care, 2009
- PLEIOTROPIC EFFECTS OF STATINSAnnual Review of Pharmacology and Toxicology, 2005
- Cholesterol-independent Effects of Statins and New Therapeutic Targets: Ischemic Stroke and DementiaJournal of Atherosclerosis and Thrombosis, 2004
- Isoprenoid metabolism and the pleiotropic effects of statinsCurrent Atherosclerosis Reports, 2003
- Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductaseAmerican Heart Journal, 2002
- Statins: mechanism of action and effectsJournal of Cellular and Molecular Medicine, 2001
- The evolving role of statins in the management of atherosclerosisJACC, 2000